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A B S T R A C T
In recent years there has been an increasing focus on the relation between cerebrovascular health, physical
exercise and Alzheimer's disease. The aim of the current study was to determine the eﬀect of moderate-to-high-
intensity aerobic exercise on cerebral blood ﬂow in patients with mild to moderate Alzheimer's disease. Fifty-one
patients were randomized to either usual care or moderate-to-high intensity aerobic exercise for 16 weeks.
Exercise had no consistent eﬀect on whole brain or regional cerebral blood ﬂow. Sixteen weeks of exercise are,
therefore, not suﬃcient to produce a consistent increase in cerebral blood ﬂow in a relatively small sample of
Alzheimer's patients.
1. Introduction
Alzheimer's disease (AD) poses a large burden on our increasingly
aging population. In addition to its characteristic Amyloid β and Tau
pathology, Alzheimer's disease is also marked by changes in cerebral
blood ﬂow (CBF) as AD patients show a 40% decrease in global blood
ﬂow compared to healthy controls (Austin et al., 2011). A decreased
CBF already occurs in individuals with mild cognitive impairment
(MCI) before their transition to AD (Binnewijzend et al., 2013). Certain
regions appear to show a particularly decreased CBF in AD, including
the precuneus, hippocampus, and posterior cingulate gyrus (Austin
et al., 2011; Binnewijzend et al., 2013; van Osch and M, 2011). Inter-
estingly, local hyperperfusion has also been reported despite a global
CBF reduction, which has been hypothesized to be a compensatory
mechanism (Austin et al., 2011).
CBF also provides a method to assess disease severity, as it is as-
sociated with cognitive functioning even within a group of AD patients
(Eggermont et al., 2006; Tosun et al., 2016). Moreover, a lower CBF as
measured with ASL MRI is related to the rate of future cognitive decline
in both healthy elderly individuals and AD patients (Benedictus et al.,
2017; Chao et al., 2010; De Vis et al., n.d.; Wolters et al., 2017;
Xekardaki et al., 2014). These ﬁndings mark CBF as a potential target
for interventions. Interestingly, in healthy individuals the association
between age and gray matter CBF is mediated by cardiorespiratory
ﬁtness (Zimmerman et al., 2014). As well, aerobic exercise has been
shown to both mitigate the eﬀect of age on CBF and improve cognition
in healthy individuals (Ainslie et al., 2008; Lucas et al., 2012). Thereby,
increasing cardiorespiratory ﬁtness may aid in preventing or slowing
pathological cognitive decline by increasing CBF. In earlier studies
regular exercise was reported to improve cognitive function and low-
ering the risk of future MCI and dementia (Ahlskog et al., 2011). As
well, various studies have shown a beneﬁcial eﬀect of physical exercise
on cognition in individuals with dementia (Groot et al., 2016).
The aim of the current study was to determine the eﬀect of mod-
erate-to-high-intensity aerobic exercise on cerebral blood ﬂow in pa-
tients with Alzheimer's disease (AD).
2. Materials and methods
The ADEX study (ClinicalTrials.gov no.: NCT01681602) is a
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multicenter, single-blind, randomized, controlled trial to investigate
whether a supervised aerobic exercise program could ameliorate
symptoms of AD. The ADEX trial was approved by the The Committees
of Biomedical Research Ethics for the Capital Region (Protocol no.: H-3-
2011-128) and by the Danish Data Protection Agency (j.no.: 30-0718).
2.1. Participants
A total of 200 patients with mild to moderate AD were randomized
to either an exercise group or to a control group (usual care). A sub-
group of patients underwent brain MRI at baseline and at 16 weeks
(Hoﬀmann et al., 2013). All participants recruited at the main three
study centers site were asked to participate in the MRI-substudy.
Among the inclusion criteria are a clinical diagnosis of probable AD, a
Mini Mental State Examination (MMSE) score of> 19 (Folstein et al.,
1975), age 50–90 years, stable dose of anti-dementia or mood stabi-
lizing medication. The exclusion criteria include contraindications for
physical activity, participation in high intensity physical exercise> 2×
per week, severe psychiatric disease or alcohol abuse within last
2 years. The inclusion criteria were described in detail earlier
(Hoﬀmann et al., 2013).
2.2. Intervention
The exercise group underwent 60min exercise sessions, three times
a week for 16 weeks. All exercise sessions were supervised. The ﬁrst
four weeks consisted of adaptation training for which participants re-
ceived an introduction to exercise session once week, and two exercise
sessions a week focusing on building strength (mostly in the legs). The
exercise sessions in the subsequent 12 weeks consisted of moderate-to-
high intensity aerobic exercise. The intensity of the exercises were ad-
justed per individual participant to target 70–80% of the heart rate
reserve. The exercises were performed on a cross trainer, bicycle and
treadmill.
The control group received care as usual.
2.3. Imaging protocol
All imaging was performed on a 3 T (Trio, Siemens, Erlangen,
Germany). The imaging protocol included a T1-weighed magnetization-
prepared rapid gradient echo (MPRAGE): TR 1550ms, TE 3.04ms, FOV
256×256, 192 slices. A Pulsed Arterial Spin Labeling (PASL) sequence
was used to obtain quantitative perfusion measurements with a ﬂow-
sensitive alternating inversion recovery (FAIR) labeling scheme, 3D
gradient-and-spin-echo (GRASE) multishot readout. PASL provides a
method to non-invasively measure cerebral perfusion through the la-
beling of blood water at the neck region. Images are acquired after a
predeﬁned post label delay when the labeled protons have reached the
tissue. The parameters of the PASL sequence were: TR 3400ms, TE
19ms, TI 2000ms, FOV 320×160, matrix 64×32, 26 slices, voxel
size 5x5x4 mm3. A Fluid Attenuated Inversion Recovery (FLAIR) se-
quence was used to calculate white matter hyperintensity (WMH vo-
lume). The FLAIR sequence parameters were: TR= 6000ms,
TE= 353ms, TI= 2200ms, FOV 256×220×192.
2.4. Data processing
To obtain quantitative perfusion maps, the obtained ASL images
were processed using IDL 6.1 for Windows (ITT Visual Information
Solutions, Boulder, C.O., U.S.A.). The quantitative perfusion maps were
registered to the T1-weighted images that were segmented using
FreeSurfer (http://freesurfer.net/fswiki/FreeSurferWiki). Whole brain
CBF was calculated, and ﬁve, bilateral regions were selected known to
be involved in AD related perfusion changes: the frontal lobe, anterior
cingulate cortex (ACC), posterior cingulate cortex (PCC), superior par-
ietal gyrus (SPG) and the precuneus (Austin et al., 2011; Binnewijzend
et al., 2013; van Osch and M, 2011). The T1-weighed images were
segmented with FreeSurfer. The PASL images were linearly registered
to the MPRAGE space to select the areas for regional CBF analysis
(https://surfer.nmr.mgh.harvard.edu/fswiki/). The absolute change in
CBF (CBFfollow-up – CBFbaseline) and relative change in CBF ((CBFfollow-up
– CBFbaseline)/CBFbaseline*100%) were calculated. Areas clearly hyper-
intense relative to surrounding white matter on both FLAIR and T2-
weighted images were delineated to obtain WMH volume. Local
thresholding was applied and WMH volumes for the whole brain were
quantiﬁed automatically using the Jim image analysis package, Version
6.0, (Xinapse Systems Ltd., Northants, UK, www.xinapse.com). Visual
identiﬁcation and delineation was carried out by a single trained rater
blinded to clinical information.
2.5. Cognitive and physical outcome measures
The Mini Mental State Examination (MMSE) was administrated at
baseline and at 16-week follow-up. VO2 peak (ml/kg/min) was re-
corded at both time points using direct breath-by breath cardio-
pulmonary exercise test (CPET) performed on a graded cycle ergometer.
Indirect calorimetry and expired gases were assembled and analyzed
using a metabolic measurement system (Jaeger, Master Screen CPX
vers. 5.21, Cardinal Health, Germany)). VO2 peak was measured at self-
termination of the test and maximal eﬀort was set at RER≥ 1.05.
(Sobol et al., 2016). VO2 peak was obtained from 34 participants.
2.6. Statistical analysis
Statistical analysis was carried out with R (R Foundation for
Statistical Computing, Vienna, Austria). Outliers were deﬁned con-
servatively as values above 4 median absolute deviations (MADs), and
they were removed from the results. Given the non-normal distribution,
the non-parametric statistical tests Wilcoxon rank-sum test, Wilcoxon
signed-rank test and Spearman's correlation were used. Bonferroni
correction was used for multiple comparisons.
3. Results
Fifty-one patients were included in the analysis (Fig. 1). Baseline
characteristics were similar between the exercise and control group
(Table 1). The similarity of the two study arms was also reﬂected in the
baseline whole brain CBF: the median CBF was 39 (interquartile range
Fig. 1. Flowchart.
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(IQR) 32–42) ml/100 g/min and 36 (IQR 31–43) for the control and
intervention group, respectively.
After the 16-week intervention the median diﬀerence in whole brain
CBF was−6 (IQR -1–3) ml/100/min for the control group and−4 (IQR
0–3) ml/100/min for the intervention group. The change in CBF over
the study period did not diﬀer between the control group subjects and
exercise group subjects (P > 0.05, Fig. 2, Table 2). The eﬀect of ex-
ercise on cardiorespiratory ﬁtness was reﬂected in the VO2 peak. There
was no diﬀerence in the VO2 peak at baseline between the exercise and
control arm (24mL/min/kg (IQR 19–29) and 24mL/min/kg (IQR
23–29, respectively)), whereas the VO2 peak was increased after
16 weeks in the exercise group (p < 0.01), but stable in the control
group (27mL/min/kg (IQR 21–32) compared to 25mL/min/kg (IQR
23–19)).
4. Discussion
Sixteen weeks of moderate-to-high intensity aerobic exercise did not
have an eﬀect on.
cerebral blood ﬂow in a group of patients with mild to moderate
Alzheimer's disease. The eﬀect of the exercise intervention on cardior-
espiratory ﬁtness (VO2 peak) did not translate to CBF. This was ob-
served for whole brain as well as for regional CBF in the frontal pre-
cuneus. The absence of detectable changes induced by the 16-week
exercise intervention is in line with results from other modalities in this
study (Hoﬀmann et al., 2016; Sobol et al., 2016; Steen Jensen et al.,
2016). Yet, an eﬀect of exercise has been reported on several neu-
ropsychological and physical function tests in the ADEX trial (Hoﬀmann
et al., 2016; Sobol et al., 2016).
These results demonstrate that although the exercise regime as used
in the ADEX trial can positively aﬀect cognition in individuals with
Alzheimer's disease, the eﬀect is not reﬂected in CBF changes. The in-
tensity of the physical exercise program was in line with guidelines for
older adults (Nelson et al., 2007; Paterson and Warburton, 2010). A
strength of this study was the close monitoring of each participant
during each exercise session, including individual adjustment to target
70–80% of the heart rate reserve. As such, adherence and proper ex-
ecution of the exercise program was monitored. A limitation of the
study is the length of the intervention, as possibly a longer trial dura-
tion would yield diﬀerent results. Still the optimal duration for such a
trial is unknown, and eﬀect of the exercise on cognition in the total
population indicates that the length was appropriate for cognitive
changes (Hoﬀmann et al., 2016). Several clinically relevant ROIs were
Table 1
Baseline characteristics.
Exercise group
(n=27)
Control group
(n= 24)
Diﬀerence between
study groups
Age (mean ± sd) 68 ± 7 69 ± 7 n.s.
Sex (female, %) 37% 41% n.s.
MMSE (mean ± sd) 25 ± 3 25 ± 3 n.s.
WMH (mm3) 3.5 ± 6.5 4.8 ± 6.1 n.s.
Hypertension 10 (37%) 11 (46%) n.s.
MMSE=mini mental state examination; WMH=white matter hyper-
intensities; n.s. = not signiﬁcant.
Fig. 2. Change in absolute CBF value (mL/100 g/min) for whole brain, frontal regions, anterior cingulate cortex (ACC), posterior cingulate cortex (PCC), superior
parietal gyrus (SPG), and the precuneus.
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selected a priori to monitor the eﬀect of exercise on CBF in AD. The
number and location of hypoperfused regions varies among studies, but
the precuneus and posterior cingulate cortex are consistently found
hypoperfused on ASL MRI in AD (Alsop et al., 2010; Schroeter et al.,
2009; Sierra-Marcos, 2017). Both regions were included in the analyses
of the current study.
The negative results might be due to mild to moderate AD diagnosis
of the participants. The disease may be too advanced to induce any CBF
increase, because chronic hypoperfusion is hypothesized to precede
neurodegeneration years before symptom onset (Daulatzai, 2017; Hays
et al., 2016). Furthermore, hypoperfusion can cause characteristic AD
pathology (Koike et al., 2011). This suggests that CBF should be tar-
geted in healthy elderly or MCI patients to prevent or postpone AD
pathology, whereas in our study population AD pathology had already
manifested. As well, the occurrence of mild small vessel disease as in-
dicated by the WMH volumes in our study may limit ability to increase
CBF, because it is also associated with decreased CBF. Several studies
have shown an eﬀect of exercise on CBF in healthy elderly (Shi et al.,
2016). Several studies have shown an eﬀect of exercise on CBF in
healthy elderly. For example, an increase in ACC CBF was found after
three months of training, whereas no change in whole brain CBF oc-
cured in healthy adults (57–75 years old) who underwent an exercise
intervention comparable to the ADEX trial (Chapman et al., 2013). In
comparison, no change in ACC CBF was found in the current study. An
increase in hippcampal CBF but no change in ACC CBF was observed in
healthy adults (70–85 yeas old) after 4months of partially unsupervised
exercise (Burdette et al., 2010). The intensity of the training program
might also aﬀect study results, as no change in CBF was found in
healthy adults (64–78 years old) who underwent an aerobic exercise
program of with less training time per session (30–60min) (Flodin
et al., 2017). In addition, a longer training period may be required to
see results in patients with advanced disease. Therefore, future studies
should consider a longer intervention or patients with less advanced
disease.
Cerebral blood ﬂow has been linked to disease severity as measured
with the MMSE in MCI and AD patients (Binnewijzend et al., 2013), and
a possible cause for the CBF reduction seen in this patient population is
amyloid deposition in the cerebral blood vessels (van Osch and M,
2011). Amyloid β is a vasoconstrictor, and may through this reduce CBF
(van Osch and M, 2011). Alternatively, the lowered CBF may reﬂect
lower metabolic demand due to tissue damage or, conversely, tissue
damage may be caused by lower CBF (Austin et al., 2011). As such, the
question of causality remains unanswered (de la Torre, 2004). It is,
however, clear that vascular risk factors play an important role in
neurodegeneration (de la Torre, 2004). In the current study, vascular
risk factors did not diﬀer between the two study arms. Interestingly, a
more active lifestyle of APOE-e4 allele carriers has been associated with
lower cerebral amyloid β deposition (Head et al., 2012). In the ADEX
trial, no eﬀect was found of the 16 week exercise program on amyloid β
concentrations in the cerebral spinal ﬂuid (Steen Jensen et al., 2016).
In summary, the results indicate that there may not be an eﬀect of
exercise on cerebral blood ﬂow in individuals with mild to moderate
AD. An alternative explanation is that 16 weeks may be too brief for
detectable eﬀects with ASL MRI in this relatively small sample.
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